Analyst Consensus ?
ConsensusBuy35 ratings
Bullish2365.7%
Neutral1131.4%
Bearish12.9%
FN2 Earnings Intelligence
Equifax Inc. (EFX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Needham | Buy | Buy | Maintain | Jul 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 22, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 22, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 2, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 19, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Feb 9, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 5, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 12, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Dec 8, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 23, 2025 |
| Jefferies | Buy | Buy | Maintain | Jan 15, 2025 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Dec 16, 2024 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 12, 2024 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Feb 13, 2024 |
| Truist Securities | Buy | Buy | Maintain | Feb 9, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Jan 11, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 8, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 21, 2023 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 15, 2022 |
| Argus Research | Buy | Hold | Upgrade | Oct 22, 2021 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Jun 9, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 21, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 18, 2020 |
| Bank of America | Underperform | Underperform | Maintain | Oct 2, 2019 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 26, 2019 |
| Argus | Hold | Hold | Maintain | Sep 15, 2017 |
| William Blair | Outperform | Outperform | Maintain | Apr 8, 2016 |
| Cowen & Co. | Outperform | Outperform | Maintain | Mar 30, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Feb 18, 2014 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Feb 19, 2013 |
Upside is calculated against the persisted current price $176.13. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $208 | $169.84 | +18.1% | Jul 22, 2026 |
| Needham | Kyle Peterson | $245 | $173 | +39.1% | Jul 22, 2026 |
| Wells Fargo | Jason Haas | $212 | $173 | +20.4% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $225 | $173 | +27.7% | Jul 22, 2026 |
| Robert W. Baird | Analyst unavailable | $232 | $173 | +31.7% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $200 | $173 | +13.6% | Jul 22, 2026 |
| RBC Capital | Ashish Sabadra | $194 | $173 | +10.1% | Jul 22, 2026 |
| Goldman Sachs | George Tong | $182 | $173 | +3.3% | Jul 21, 2026 |
| Mizuho Securities | Analyst unavailable | $210 | $167.22 | +19.2% | Jul 2, 2026 |
| Goldman Sachs | George Tong | $173 | $151.93 | -1.8% | Jun 26, 2026 |
| Wells Fargo | Analyst unavailable | $220 | $154.84 | +24.9% | Jun 18, 2026 |
| UBS | Analyst unavailable | $215 | $165.13 | +22.1% | Jun 16, 2026 |
| UBS | Kevin McVeigh | $220 | $176.38 | +24.9% | Apr 23, 2026 |
| Mizuho Securities | Analyst unavailable | $222 | $186.85 | +26.0% | Apr 16, 2026 |
| Goldman Sachs | Analyst unavailable | $208 | $193.55 | +18.1% | Feb 6, 2026 |
| RBC Capital | Ashish Sabadra | $222 | $188.19 | +26.0% | Feb 5, 2026 |
| Needham | Analyst unavailable | $265 | $184.57 | +50.5% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $184.63 | +33.4% | Feb 5, 2026 |
| RBC Capital | Analyst unavailable | $220 | $183.44 | +24.9% | Feb 5, 2026 |
| BMO Capital | Analyst unavailable | $195 | $181.04 | +10.7% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $250 | $181.04 | +41.9% | Feb 5, 2026 |
| UBS | Analyst unavailable | $230 | $181.04 | +30.6% | Feb 5, 2026 |
| Barclays | Manav Patnaik | $215 | $181.04 | +22.1% | Feb 5, 2026 |
| Morgan Stanley | Toni Kaplan | $244 | $181.04 | +38.5% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $280 | $220.77 | +59.0% | Dec 17, 2025 |
| BMO Capital | Analyst unavailable | $234 | $211.51 | +32.9% | Dec 8, 2025 |
| BMO Capital | Analyst unavailable | $245 | $229.93 | +39.1% | Oct 22, 2025 |
| Stifel Nicolaus | Analyst unavailable | $253 | $231.31 | +43.6% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $285 | $228.33 | +61.8% | Oct 15, 2025 |
| Oppenheimer | Analyst unavailable | $271 | $230.81 | +53.9% | Oct 13, 2025 |
| UBS | Analyst unavailable | $297 | $256.25 | +68.6% | Sep 15, 2025 |
| UBS | Kevin McVeigh | $278 | $243.56 | +57.8% | Jul 23, 2025 |
| Bank of America Securities | Joshua Dennerlein | $285 | $255.08 | +61.8% | Jun 23, 2025 |
| RBC Capital | Ashish Sabadra | $300 | $243.45 | +70.3% | Mar 20, 2025 |
| BNP Paribas | Andrew Grobler | $305 | $260.55 | +73.2% | Dec 16, 2024 |
| Citigroup | Arthur Truslove | $331 | $285.2 | +87.9% | Oct 11, 2024 |
| BNP Paribas | Andrew Grobler | $310 | $297.57 | +76.0% | Sep 19, 2024 |
| Barclays | Manav Patnaik | $380 | $297.77 | +115.7% | Sep 13, 2024 |
| New Street | Toni Kaplan | $271 | $297.99 | +53.9% | Sep 12, 2024 |
| Needham | Kyle Peterson | $350 | $305.12 | +98.7% | Aug 28, 2024 |
| Wells Fargo | Jason Haas | $340 | $283.59 | +93.0% | Aug 12, 2024 |
| Needham | Kyle Peterson | $320 | $265.9 | +81.7% | Jul 19, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $305 | $264.19 | +73.2% | Jul 19, 2024 |
| Oppenheimer | Owen Lau | $300 | $260.3 | +70.3% | Jul 19, 2024 |
| Goldman Sachs | George Tong | $277 | $264.19 | +57.3% | Jul 18, 2024 |
| Evercore ISI | David Togut | $305 | $272.15 | +73.2% | Jul 18, 2024 |
| Oppenheimer | Owen Lau | $272 | $217.51 | +54.4% | Apr 19, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $265 | $217.51 | +50.5% | Apr 19, 2024 |
| Robert W. Baird | Jeffrey Meuler | $260 | $217.51 | +47.6% | Apr 19, 2024 |
| Morgan Stanley | Toni Kaplan | $240 | $217.51 | +36.3% | Apr 18, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $295 | $262.74 | +67.5% | Apr 9, 2024 |
| Evercore ISI | David Togut | $310 | $247.94 | +76.0% | Feb 13, 2024 |
| Deutsche Bank | Faiza Alwy | $267 | $230.38 | +51.6% | Dec 7, 2023 |
| RBC Capital | Ashish Sabadra | $205 | $202.29 | +16.4% | Apr 21, 2023 |
| Truist Financial | Analyst unavailable | $260 | $222.56 | +47.6% | Feb 6, 2023 |
| Wells Fargo | Analyst unavailable | $210 | $217.56 | +19.2% | Jan 13, 2023 |
| Morgan Stanley | Analyst unavailable | $197 | $205.76 | +11.8% | Jan 4, 2023 |
| Stifel Nicolaus | Stifel Stifel | $222 | $192.63 | +26.0% | Dec 16, 2022 |
| J.P. Morgan | Analyst unavailable | $219 | $201.85 | +24.3% | Nov 18, 2022 |
| Atlantic Equities | Simon Clinch | $230 | $207.1 | +30.6% | Nov 15, 2022 |
| Needham | Analyst unavailable | $230 | $193.99 | +30.6% | Nov 14, 2022 |
| Morgan Stanley | Analyst unavailable | $212 | $172.07 | +20.4% | Sep 27, 2022 |
| Barclays | Analyst unavailable | $230 | $193.99 | +30.6% | Jul 27, 2022 |
| Deutsche Bank | Analyst unavailable | $221 | $201.22 | +25.5% | Jul 22, 2022 |
| Truist Financial | Andrew Jeffrey | $230 | $200.56 | +30.6% | Jul 22, 2022 |
| Morgan Stanley | Analyst unavailable | $230 | $200.56 | +30.6% | Jul 22, 2022 |
| Credit Suisse | Analyst unavailable | $245 | $200.52 | +39.1% | Jul 21, 2022 |
| Stifel Nicolaus | Analyst unavailable | $223 | $183.14 | +26.6% | Jul 1, 2022 |
| Morgan Stanley | Toni Kaplan | $227 | $184.94 | +28.9% | Jun 28, 2022 |
| Evercore ISI | David Togut | $200 | $203.52 | +13.6% | Apr 29, 2022 |
| Barclays | Analyst unavailable | $250 | $206.53 | +41.9% | Apr 22, 2022 |
| Credit Suisse | Analyst unavailable | $250 | $206.44 | +41.9% | Apr 22, 2022 |
| Deutsche Bank | Analyst unavailable | $225 | $202.95 | +27.7% | Apr 22, 2022 |
| Goldman Sachs | George Tong | $221 | $202.95 | +25.5% | Apr 21, 2022 |
| RBC Capital | Analyst unavailable | $244 | $221.41 | +38.5% | Apr 21, 2022 |
| Morgan Stanley | Toni Kaplan | $250 | $202.95 | +41.9% | Apr 21, 2022 |
| Needham | Kyle Peterson | $275 | $202.95 | +56.1% | Apr 21, 2022 |
| Robert W. Baird | Jeffrey Meuler | $281 | $221.41 | +59.5% | Apr 20, 2022 |
| Deutsche Bank | Faiza Alwy | $265 | $214.14 | +50.5% | Apr 18, 2022 |
| Barclays | Manav Patnaik | $300 | $235.46 | +70.3% | Mar 27, 2022 |
| Cowen & Co. | Georgios Mihalos | $295 | $228.23 | +67.5% | Jan 20, 2022 |
| BNP Paribas | George Gregory | $290 | $280.26 | +64.7% | Nov 22, 2021 |
| Jefferies | Hamzah Mazari | $320 | $274.74 | +81.7% | Nov 11, 2021 |
| Argus Research | David Coleman | $285 | $267.42 | +61.8% | Oct 22, 2021 |
| Goldman Sachs | George Tong | $267 | $248.56 | +51.6% | Jul 22, 2021 |
| Credit Suisse | Kevin Mcveigh | $270 | $220.02 | +53.3% | Apr 22, 2021 |
Track every rating change on EFX the moment it posts. Free to start.
Start free